Roche’s (OTCQX:RHHBY) Genentech unit plans to invest more than $700M in a new drug manufacturing facility in Holly Springs, North Carolina. The announcements reflect a broader wave of major ...

Roche and Genentech Announce New North Carolina Manufacturing Facility. Genentech ... Regeneron, Roche Launch Major US Expansion Plans to Meet Growing Demand for Biologics and Innovation. PharmExec.

May 12, 2025--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX ... Genentech CEO Ashley Magargee: "Our new facility near Raleigh, North Carolina, an established biopharmaceutical ...

May 12 (Reuters) - Roche Group (ROG.S), opens new tab said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North Carolina, the latest drugmaker to ...

(RTTNews) - Roche Holding AG (RHHBY), Monday announced plans to invest over $700 million in a new state-of-the-art drug manufacturing facility in Holly Springs, North Carolina, creating more than ...

facility in Holly Springs ... and advance cutting-edge scientific innovation right here in North Carolina.” Together, Roche and Genentech are advocating for a vibrant biotech community and ...